147 related articles for article (PubMed ID: 6495266)
1. Elimination of intravenously administered radiolabelled antithrombin III and heparin in humans.
de Swart CA; Nijmeyer B; Andersson LO; Holmer E; Sixma JJ; Bouma BN
Thromb Haemost; 1984 Aug; 52(1):66-70. PubMed ID: 6495266
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
Jørgensen M; Petersen LC; Thorsen S
J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
[TBL] [Abstract][Full Text] [Related]
3. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity.
Howarth DJ; Samson D; Stirling Y; Seghatchian MJ
Thromb Haemost; 1985 Jun; 53(3):314-9. PubMed ID: 4049307
[TBL] [Abstract][Full Text] [Related]
4. Covalent complexes between low molecular weight heparin fragments and antithrombin III - inhibition kinetics and turnover parameters.
Hoylaerts M; Holmer E; de Mol M; Collen D
Thromb Haemost; 1983 Apr; 49(2):109-15. PubMed ID: 6868006
[TBL] [Abstract][Full Text] [Related]
5. Correlation of in vivo and in vitro inhibition of thrombin by plasma inhibitors.
Vogel CN; Kingdon HS; Lundblad RL
J Lab Clin Med; 1979 Apr; 93(4):661-73. PubMed ID: 429864
[TBL] [Abstract][Full Text] [Related]
6. Interaction of heparin with histidine-rich glycoprotein and with antithrombin III.
Lijnen HR; van Hoef B; Collen D
Thromb Haemost; 1983 Aug; 50(2):560-2. PubMed ID: 6415849
[TBL] [Abstract][Full Text] [Related]
7. Fate of thrombin and thrombin-antithrombin-III complex adsorbed to a heparinized biomaterial: analysis of the enzyme-inhibitor complexes displaced by plasma.
Hatton MW; Rollason G; Sefton MV
Thromb Haemost; 1983 Dec; 50(4):873-7. PubMed ID: 6198746
[TBL] [Abstract][Full Text] [Related]
8. Binding of heparin fractions to von Willebrand factor: effect of molecular weight and affinity for antithrombin III.
Baruch D; Ajzenberg N; Denis C; Legendre P; Lormeau JC; Meyer D
Thromb Haemost; 1994 Jan; 71(1):141-6. PubMed ID: 8165633
[TBL] [Abstract][Full Text] [Related]
9. Elimination of high affinity heparin fractions and their anticoagulant and lipase activity.
de Swart CA; Nijmeyer B; Andersson LO; Holmer E; Verschoor L; Bouma BN; Sixma JJ
Blood; 1984 Apr; 63(4):836-42. PubMed ID: 6704544
[TBL] [Abstract][Full Text] [Related]
10. The interaction of heparin with plasma proteins. Demonstration of different binding sites for antithrombin III complexes and antithrombin III.
McKay EJ; Laurell CB
J Lab Clin Med; 1980 Jan; 95(1):69-80. PubMed ID: 7350242
[TBL] [Abstract][Full Text] [Related]
11. [A method of determining heparin in blood plasma based on its antithrombin activity].
Taktashev RE; Suvorova AV; Miller VE; Kolesnikova OI
Lab Delo; 1990; (12):59-61. PubMed ID: 1710698
[TBL] [Abstract][Full Text] [Related]
12. High molecular weight forms of antithrombin III complexes in blood.
Marciniak E; Gora-Maslak G
Thromb Haemost; 1983 Feb; 49(1):32-6. PubMed ID: 6845270
[TBL] [Abstract][Full Text] [Related]
13. Contribution of red blood cells to the saturable mechanism of heparin clearance.
Young E; Hirsh J
Thromb Haemost; 1990 Dec; 64(4):559-63. PubMed ID: 2084941
[TBL] [Abstract][Full Text] [Related]
14. Comparative turn-over of heparin cofactor II and antithrombin III in baboons. Influence of heparin and pentosan polysulfate administration.
Sié P; Lansen J; Lacheretz F; Verschuere B; Boneu B
Thromb Haemost; 1986 Dec; 56(3):302-7. PubMed ID: 2436331
[TBL] [Abstract][Full Text] [Related]
15. [Antithrombin III activity in relation to multiple administration of various doses of heparin to normal animals].
Kudriashov BA; Pastorova VE; Liapina LA
Vopr Med Khim; 1985; 31(3):37-41. PubMed ID: 4024529
[TBL] [Abstract][Full Text] [Related]
16. Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity.
Olson ST; Frances-Chmura AM; Swanson R; Björk I; Zettlmeissl G
Arch Biochem Biophys; 1997 May; 341(2):212-21. PubMed ID: 9169007
[TBL] [Abstract][Full Text] [Related]
17. Studies of heparin affinity to antithrombin III and other proteins in vitro and in vivo.
Takeda Y; Kobayashi N
Thromb Haemost; 1977 Oct; 38(3):685-95. PubMed ID: 579514
[No Abstract] [Full Text] [Related]
18. Heparin elimination in patients with liver cirrhosis.
Teien AN
Thromb Haemost; 1977 Oct; 38(3):701-6. PubMed ID: 579516
[TBL] [Abstract][Full Text] [Related]
19. Turnover study of heparin cofactor II in healthy man.
Sié P; Dupouy D; Pichon J; Boneu B
Thromb Haemost; 1985 Oct; 54(3):635-8. PubMed ID: 3841420
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration.
Collen D; Schetz J; de Cock F; Holmer E; Verstraete M
Eur J Clin Invest; 1977 Feb; 7(1):27-35. PubMed ID: 65284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
